In addition to loss of heterozygosity, the second hit in sporadic breast cancers with breast cancer gene 1 (BRCA1) or breast cancer gene 2 (BRCA2) mutations is often which of the following?
Which of the following can be cancer-associated genes by virtue of their ability to directly regulate the expression of protooncogenes and tumor suppressors, but which themselves are noncoding?